To evaluate the sensitivity and specificity of core needle biopsy in determining musculoskeletal tumours in our hospital. Methods. Records of 134 patients who underwent core needle biopsy followed by definitive surgery were retrospectively reviewed. Results of the core needle biopsy were compared with those of the final histology. Histology was classified into benign versus malignant, and bony versus soft-tissue lesions. The sensitivity and specificity of core needle biopsy were calculated. results. Based on final histology, there were 33 bone tumours (3 benign and 30 malignant), 74 softtissue tumours (6 benign and 68 malignant), 11 schwannomas (7 benign and 4 malignant), and 16 inflammatory/necrotic (benign) lesions. For 118 (88%) tumours, the biopsy results matched the final histological results. For 7 tumours, biopsy results were non-diagnostic, as the amount of tissue obtained was insufficient. For 9 tumours, biopsy results did not match the final histological results; 5 considered benign but turned out to be malignant, one considered malignant but turned out to be benign, and 3 were correctly identified as malignant but incorrectly subtyped. The sensitivity and specificity of core needle biopsy were 95% (97/102) and 97% (31/32), respectively, assuming that the 7 non-diagnostic tumours were correctly diagnosed. conclusion. Core needle biopsy is an accurate and reliable diagnostic tool for musculoskeletal tumours if performed by skilled persons and adequate tissue is obtained.
consuming. 1, 2 An inappropriately placed incision can complicate subsequent surgical resection. 1 The complication rate of open biopsy is reported to be 16%; 8% of the treatment plans are affected by these complications. 3 Core needle biopsy decreases morbidity, costs and time, and results in fewer complications. It can be performed under local anaesthesia in an outpatient setting. Its accuracy has been reported to be 76 to 99%. [4] [5] [6] [7] [8] [9] [10] [11] It has high sensitivity and specificity in primary, locally recurrent, or metastatic lesions in various anatomic locations. 4, 6, 12 Nonetheless, its use remains limited. In a pattern-of-care survey by the American College of Surgeons, of 3457 patients with sarcomas treated from 1983 to 1984, only 9% underwent a needle biopsy. 13 In an informal survey at 1999, only 40% of surgeons used needle biopsy for diagnosis of mesenchymal tumours over the previous 15 years. 14 Percutaneous needle biopsy is effective and safe for the diagnosis of musculoskeletal tumours; 88% of patients with suspected sarcomas underwent a single-needle biopsy before definitive treatment. 14 We evaluated the sensitivity and specificity of core needle biopsy in determining musculoskeletal tumours in our hospital.
Materials and Methods
Records of 151 patients who underwent core needle biopsy using the Tru-cut system (Baxter Health Care, Valencia [CA], USA) from May 1999 to November 2010 were retrospectively reviewed. 134 of them underwent definitive surgery at which the final histology was obtained. The remaining 17 did not undergo any definitive surgery because their lesions were considered benign or they were lost to followup.
Prior to biopsy, radiography, computed tomography (CT), and/or magnetic resonance imaging (MRI) was performed. Cross-sectional images were reviewed by both musculoskeletal radiologist and surgeon to (1) select a biopsy entry site and pathway that align with the plane of the incision for definitive surgery so that the biopsy track would be excised with the primary tumour, and (2) visualise the interface between the tumour and nearby major neurovascular bundle so as to reduce the risk of injury and contamination of major neurovascular structures.
Non-steroidal anti-inflammatory drug or oral opioid was given at least one hour before the procedure. The patient was prepped and draped, and then anaesthesised with 1% lignocaine. The needle passed through the same puncture site, and 3 to 5 core tissue samples were obtained in different directions to ensure diverse sampling. All patients tolerated the procedure well with only mild pain (visual analogue score, <3). For any non-palpable mass confined to the bone or pelvis, CT guidance was used. The mean radiation for each biopsy was 6 milli-sieverts for a 16-slice multidetector spiral CT machine.
No patient had any major post-biopsy complications. Some patients had wound bruising, but none underwent surgery for haematoma evacuation or was hospitalised.
To reduce bias, biopsy specimens were reviewed by a single musculoskeletal pathologist. Results of the core needle biopsy were compared with those of the final histology after definitive surgery. Histology was classified into benign versus malignant, and bony versus soft-tissue lesions. The sensitivity and specificity of core needle biopsy were calculated.
results
Based on final histology, there were 33 bone tumours (3 benign and 30 malignant), 74 soft-tissue tumours (6 benign and 68 malignant), 11 schwannomas (7 benign and 4 malignant), and 16 inflammatory/necrotic (benign) lesions (Table 1 ). For 118 (88%) tumours, the biopsy results matched the final histological results. For 7 tumours, biopsy results were non-diagnostic, as the amount of tissue obtained was insufficient. For 9 tumours, biopsy results did not match the final histological results ( Table 2) ; 5 considered benign but turned out to be malignant, one considered malignant but turned out to be benign, and 3 were correctly identified as malignant but incorrectly subtyped. The sensitivity and specificity of core needle biopsy were 95% (97/102) and 97% (31/32), respectively, assuming that the 7 non-diagnostic tumours were correctly diagnosed.
For bone tumours, the diagnostic accuracy was 94% (31/33); 2 lesions considered benign but turned out to be malignant (osteosarcoma and chondrosarcoma). In one patient, MRI revealed a large intramuscular mass suspicious of a malignant tumour despite biopsy showing infarcted fibrinous tissue. Surgical resection was advised and the patient underwent wide excision of the right medial groin tumour, which was confirmed to be chondrosarcoma. The excision margins were clear, and the patient underwent postoperative chemotherapy and radiotherapy and had no recurrence for at least 3 years. In another patient, an osteoma was resected in 2005. Five years later, the tumour recurred and a biopsy revealed fibroconnective tissue. Nonetheless, surgical resection was advised, and the patient underwent wide excision with adjuvant chemotherapy and histology. The tumour turned out to be an osteosarcoma. The patient had no recurrence for at least 2 years.
For soft-tissue tumours, the diagnostic accuracy was 96% (71/74); 3 lesions considered benign but turned out to be an anaplastic large cell lymphoma, a large B-cell lymphoma, and a fibrosarcoma. In the first patient, a 5-cm fungating exophytic mass on the right arm was thought to be an inflammatory mass. The patient underwent wide resection and postoperative chemotherapy and had no recurrence for 4 years. In the second patient, MRI showed a lesion in the right distal femur involving the diaphysis, metaphysis, and epiphysis with extension into the soft-tissue deep to the vastus intermedius. Biopsy showed dense sclerotic fibrocollagenous tissue. The patient underwent excision, curettage, and polymethylmethacrylate cementation. In the third patient, a right gluteal mass was thought to be a fibroconnective tissue with foci of foreign giant cell reaction. Despite undergoing wide resection, brachytherapy, and radiotherapy, the patient had recurrences and underwent 4 more wide excisions, the latest one in April 2011.
One patient was considered to have a soft-tissue sarcoma in the posterior medial aspect of the right heel, but turned out to have a schwannoma (benign). Intra-operatively, the posterior tibial neurovascular bundle was found to be encased by the tumour. Postoperatively, the patient had numbness of the heel and plantar aspect of the foot.
In 3 patients, the tumours were correctly identified as malignant but incorrectly subtyped. The first one was a liposarcoma but turned out to be a fibrosarcoma. The patient underwent wide resection and postoperative chemotherapy and did not have recurrence for at least 5 years. The second one was a soft-tissue leiomyosarcoma but turned out to be a liposarcoma. The patient had no recurrence after radical excision. The third one was a soft-tissue desmoplastic small round cell tumour but turned out to be an osteosarcoma. The patient underwent wide excision and postoperative chemotherapy and radiotherapy and had no recurrence for at least 5 years.
Core needle biopsy diagnosis Final histological diagnosis
Benign but turn out malignant (n=5) Benign inflammatory mass Anaplastic large cell lymphoma Dense sclerotic fibrocollagenous tissue Large B-cell lymphoma Fibroconnective tissue with foci of foreign body giant cell reaction Fibrosarcoma Infarcted fibrinous tissue (no viable tumour tissue is identified, an excisional biopsy is advised)
Chondrosarcoma
Fibroconnective tissue, fibroadipose tissue Osteosarcoma Malignant but turn out benign (n=1) Soft-tissue sarcoma Schwannoma Correct in malignancy but incorrect in subtypes (n=3) Leiomyosarcoma Liposarcoma Liposarcoma Fibrosarcoma Desmoplastic small round cell tumour Osteosarcoma 
